483 Lonza AG Mar 2016

483 Lonza AG Mar 2016

Xiaokuang Lai FDA, Libia Lugo FDA$119.00 - Available Now

FDA investigators audited the Lonza AG - Visp, Switzerland facility and issued inspectional observations (via FDA 483) on 11 Mar 2016.

Product details

  • Category: Human Drugs
  • Inspection end: 11 Mar 2016
  • Location: Visp, Switzerland
  • FEI: 3002930340
Add To Cart